Biostroke Me...

We cordially invite you to join the 3rd BIOSTROKE Meeting, taking place at the historic Hohenkammer Castle near Munich from March 15 to 17, 2027.  

BIOSTROKE offers a unique platform to advance biomarker science in stroke care and foster interdisciplinary collaboration between experts in stroke biomarker research, cardiovascular medicine, and neuroscience. Bringing together 120 participants, the meeting will facilitate in-depth scientific exchange on the most pressing, unsolved challenges in clinical decision-making with sessions across the stroke care continuum – from acute management to secondary prevention and long-term recovery. The program features talks by internationally recognized leaders, alongside presentations selected from submitted abstracts. The format prioritizes open discussion and informal interactions among scientists of all career levels.

Endorsement by the European Stroke Organization (ESO) and the European Society of Minimally Invasive Neurological Therapy (ESMINT) as well as CME/CPD accreditation are currently in process.

Participation requires registration* via this website (soon!).

We look forward to welcoming you in Munich in March 2027!

John McCabe, Johanna Ospel, Steffen Tiedt

Participation in the conference is limited to 120 attendees, with seats allocated on a first-come, first-served basis. We strongly encourage participation from PhD students, postdoctoral researchers, and scientists from underrepresented backgrounds. To support the next generation of researchers, 30 seats are reserved for early career investigators – including students, postdocs, and residents – at a reduced registration rate. Once these spots are filled, early career participants are welcome to register at the regular rate.

Registration includes:

• Access to all talks and poster sessions
• Accommodation (single room, 2 nights from March 15-17 2027 at Castle Hohenkammer, Munich)
• All meals and coffee breaks (not including extra alcoholic beverages)

This registration link is intended for academic participants and clinicians. Industry representatives who are interested in attending are kindly asked to contact the organizers directly.

The Program will be published soon.

Abstract submission will open soon. Abstracts on recent and unpublished research will be chosen for short talks or poster sessions by the abstract selection committee. 

Tiedt S, et al. Biomarkers for advancing diagnosis and prognosis in stroke, The Lancet Neurology, Volume 25, Issue 4, 2026, Pages 406-420, ISSN 1474-4422, https://doi.org/10.1016/S1474-4422(25)00480-6.

Downloads:

• Research priorities for stroke biomarker development
• Reporting_datasets_prehospital_stroke
• Reporting_datasets_plaque_vulnerability
• Reporting_datasets_ischaemic_stroke_progression_recovery
• Reporting_datasets_ICH_progression
• Reporting_datasets_ICH_diagnosis
• Reporting_datasets_ICH_complications
• Reporting_datasets_atrial_cardiopathy
• Proposed_definitions_items